Delphic is working with an international panel of HIV experts to develop Inhibitory Quotients (IQs) for routine clinical use. An IQ characterises the relationship between drug exposure (pharmacology) and drug susceptibility (virology). A clinician is able to offer individualised care, balancing a patient’s tolerance of a drug with the resistance of their virus to that drug.

If you are interested in participating in our programme of key centre service testing to receive real-time IQ results with your TDM report, please contact us.